CAS NO: | 56238-63-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
500mg | 电议 |
1 g | 电议 |
5 g | 电议 |
10 g | 电议 |
生物活性 | Cefuroxime sodium is an orally active second-generation cephalosporinantibioticwith increased stability toβ-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1]. | ||||||||||||||||
体外研究 (In Vitro) | Cefuroxime sodium is highly active againstS. aureus(MIC=0.25 μg/ml), regardless of whether the strains produces a penicillinase. It is againstStaphylococcus aureusmethicillin susceptible;S. aureus, methicillin resistant,Streptococcus pyogenes,S. pneumoniae,S. viridans,S. faecalis, andClostridium sppwith MIC values of 0.25 μg/ml, 5.9 μg/ml, 0.125 μg/ml, 0.125 μg/ml, 0.125 μg/ml, >125.0 μg/ml, and 1.2 μg/ml, respectively[1].Cefuroxime sodium (10-100 μg/ml; 2-6 hours) rapidly bactericidal, its action is comparatively slow against the strains ofS. aureus, but, even so, over 99% of the initial inoculum is killed by 6 h. The gram-negative organisms are killed rapidly, and in most cases over 99% of the very large inocula are killed within 2 h; the β-lactamase-producing strains are killed as quickly as non-enzyme-producing strains[1]. | ||||||||||||||||
体内研究 (In Vivo) | Rabbits (weighing 2.0 to 2.5 kg) are challenged intravenously withS. aureusstrain 630 (a penicillinase-producing strain), the median effective dose of Cefuroxime sodium is 3 mg/kg as a result of the protection test[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 446.37 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H15N4NaO8S | ||||||||||||||||
CAS 号 | 56238-63-2 | ||||||||||||||||
中文名称 | 头孢呋辛钠;头孢呋新钠;头孢呋肟钠;呋肟霉素钠 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(224.03 mM) H2O : 50 mg/mL(112.01 mM;Need ultrasonic) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|